Sort
40,608 grants matching “prostate cancer”
Microbes and Human Malignancies
$486,661James J Goedert · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Understanding optimal delivery systems for cancer care
$486,648David C Miller · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort
$486,574Mia Hashibe · University Of Utah · R01 · FY2021 · CA
CLINICAL TRIAL: THE SELENIUM AND VITAMIN E CHEMOPREVENTION TRIAL (SELECT)
$486,559Rowan A Chlebowski · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · M01 · FY2010 · RR
NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma
$486,559Xiao-Fan Wang · Duke University · R01 · FY2024 · CA
Genetic Epidemiology of Prostate Cancer
$486,482Janet L Stanford · Fred Hutchinson Cancer Research Center · R01 · FY2007 · CA
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
$486,467Srinivas Raghavan Viswanathan · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Robot-Assisted MRI-Guided Prostate Biopsy
$486,361Dan Stoianovici · Johns Hopkins University · RC1 · FY2010 · EB
Real time fine needle assessment of architectural heterogeneity in prostate cancer
$486,336Guan Xu · University Of Michigan At Ann Arbor · R37 · FY2022 · CA
Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer
$486,167Barbara A Cohn · Public Health Institute · R01 · FY2024 · CA
RIPK2/MKK7/c-Myc Signaling as a Therapeutic Target in Prostate Cancer Metastasis
$486,109Wei Yang · State University New York Stony Brook · R01 · FY2023 · CA
Validating and Extending the PROMIS Sexual Function Measure for Clinical Research
$486,108Kevin P Weinfurt · Duke University · U01 · FY2012 · AR
Validating and Extending the PROMIS Sexual Function Measure for Clinical Research
$486,108Kevin P Weinfurt · Duke University · U01 · FY2011 · AR
Clinical and Analytical Validation of Cancer Biomarkers
$486,000Daniel W Chan · Johns Hopkins University · U24 · FY2017 · CA
NOVEL REGULATORS OF LINEAGE PLASTICITY IN CASTRATION-RESISTANT PROSTATE CANCER
$486,000The Trustees Of Columbia University In The City Of New York · · FY2022 · Department of the Army
Clinical and Analytical Validation of Cancer Biomarkers
$486,000Daniel W Chan · Johns Hopkins University · U24 · FY2020 · CA
ROLE OF ATAD2 IN PROSTATE CANCER BONE METASTASIS
$486,000The Trustees Of Columbia University In The City Of New York · · FY2022 · Defense Health Agency
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$485,992William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Utilizing islet autoantibody signatures for precision medicine in type 2 diabetes
$485,960Nisa M Maruthur · Johns Hopkins University · R01 · FY2022 · DK
Genetic Epidemiology of Prostate Cancer Aggressiveness
$485,892John S Witte · University Of California, San Francisco · R01 · FY2011 · CA
Elucidating the molecular signaling of Cadmium Carcinogenesis
$485,844Chendil Damodaran · Texas A&M University Health Science Ctr · R01 · FY2024 · ES
Mechanisms of targeting cellular self-renewal in glioblastoma
$485,837Hatem Sabaawy · Rbhs -Cancer Institute Of New Jersey · R01 · FY2021 · CA
Acquisition of a Q-Exactive Plus Mass Spectrometer
$485,813William T Jewell · University Of California At Davis · S10 · FY2019 · OD
LHRH Synthetic Peptide Vaccine for Prostate Cancer
$485,806United Biomedical, Inc. · R44 · FY2003 · CA
TiO2 nanocomposites for Targeted Treatment and Imaging of Prostate cancer
$485,759Gayle E Woloschak · Northwestern University At Chicago · U54 · FY2009 · CA